|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0004083,
umls-concept:C0018787,
umls-concept:C0018801,
umls-concept:C0026538,
umls-concept:C0026565,
umls-concept:C0027976,
umls-concept:C0031809,
umls-concept:C0205245,
umls-concept:C0301630,
umls-concept:C0456387,
umls-concept:C0717550,
umls-concept:C1274040,
umls-concept:C1280500
|
|
pubmed:issue |
21
|
|
pubmed:dateCreated |
2004-11-3
|
|
pubmed:abstractText |
To evaluate the effect of the angiotensin receptor blocker candesartan on New York Heart Association (NYHA) functional class in a broad spectrum of patients with chronic heart failure (CHF).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0195-668X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1920-6
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15522471-Adult,
pubmed-meshheading:15522471-Aged,
pubmed-meshheading:15522471-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:15522471-Benzimidazoles,
pubmed-meshheading:15522471-Female,
pubmed-meshheading:15522471-Heart Failure,
pubmed-meshheading:15522471-Humans,
pubmed-meshheading:15522471-Male,
pubmed-meshheading:15522471-Middle Aged,
pubmed-meshheading:15522471-Tetrazoles,
pubmed-meshheading:15522471-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Effect of candesartan on New York Heart Association functional class. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.
|
|
pubmed:affiliation |
Department of Cardiology, Western Infirmary, Glasgow, Scotland, UK.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|
